Fasting plasma glucose and subsequent macrovascular disease after 10 years follow-up: A collaborative study on two populations

QJM: An International Journal of Medicine

Volumn 92, Issue 4, 1999, Pages 207-210

  Yarnell, J W G ^a,c   Patterson, C C ^a   Thomas, H F ^b   Sweetnam, P M ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIET RESTRICTION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; UNITED KINGDOM; VASCULAR DISEASE;

EID: 0032938204     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/92.4.207     Document Type: Article

References (15)

1. American Diabetes Association Expert Committee. Report on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183-97.
2. World Health Organisation Study Group. Diabetes mellitus. WHO Tech Rep Ser 1985; No. 727.
3. Andres R, et al. quoted in reference 1 as personal communication (1997).
4. Charles MA, Balkau B, Vauzelle-Kervroedan F, Thibult N, Eschwège E. Revision of diagnostic criteria for diabetes. Lancet 1996; 348:1657-8.
5. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. Br Med J 1998; 317:371-5.
6. Yarnell JWC, Pickering JE, Elwood PC, Baker IA, Bainton D, Dawkins C, Phillips DIW. Does non-diabetic hyperglycemia predict future IHD? Evidence from the Caerphilly and Speedwell Studies. J Clin Epidemiol 1994; 47:383-8.
7. Bainton D, Miller NE, Bolton CH, Yarnell JWC, Sweetnam PM, Baker IA, Lewis B, Elwood PC. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. Br Heart J 1992; 68:60-6.
8. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods, 2nd edn. World Health Organization, Geneva, 1982.
9. WHO MONICA Project (prepared by Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas A-M, Pajak A). Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 Populations from 21 countries in four continents. Circulation 1994; 90:583-612.
10. Kadish AH, Little RL, Sternberg JC. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 1968; 14:116-31.
11. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study. Br Med J 1983; 287:867-70.
12. Yarnell JWG, Patterson CC, Bainton D, Sweetnam PM. Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies. Heart 1998; 79:248-52.
13. Chaturvedi N, Jarrett J, Shipley MJ, Fuller JH. Socioeconomic gradient in morbidity and mortality in people with diabetes: cohort study findings from the Whitehall study and the WHO multinational study of vascular disease in diabetes. Br Med J 1998;316:100-6.
14. Barrett-Connor E. Does hyperglycemia really cause coronary heart disease? Diabetes Care 1997; 20:1620-3.
15. Balkau B, Shipley M, Jarrett R, Pyorala K, Pyorala M, Forhan A, Eschwège E. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year fol low-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998; 21:360-7.